The friendly use of chloroquine in the COVID-19 disease: a warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene

Clin Chem Lab Med. 2020 Jun 25;58(7):1162-1164. doi: 10.1515/cclm-2020-0442.
No abstract available

Keywords: COVID-19; Chloroquine; G6PD.

Publication types

  • Letter

MeSH terms

  • Betacoronavirus / genetics
  • Betacoronavirus / pathogenicity
  • COVID-19
  • Chloroquine / adverse effects*
  • Chloroquine / therapeutic use*
  • Coronavirus Infections / drug therapy*
  • Female
  • Glucosephosphate Dehydrogenase / drug effects*
  • Glucosephosphate Dehydrogenase / genetics
  • Glucosephosphate Dehydrogenase Deficiency / drug therapy
  • Heterozygote
  • Humans
  • Male
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • SARS-CoV-2

Substances

  • Chloroquine
  • Glucosephosphate Dehydrogenase